ScholarWorks@Korea University: Kim, Je Hyeong

Detailed Information

Kim, Je Hyeong (김제형)

College of Medicine (Department of Medical Science)

Research Area

Tel 031-412-5950
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Prognosis:4||Biomarker:3||Epidemiology:3||Nonsmall cell lung cancer:2||Reactive oxygen species:2||respiratory insufficiency:2||Procalcitonin:2||Smoking:2||Adult:2||acute respiratory distress syndrome:2||Respiration, Artificial:2||proteomics:2||Korea:2||Acute lung injury:2||Immigrants:2||Oxidative stress:2||Inflammation:2||Pneumonia:2||prevalence:2||Mortality:2||Diagnosis:2||COPD:2||Refugees:1||Latent Tuberculosis Infection:1||Therapeutics:1||Pulmonary sarcomatoid carcinoma:1||Strains:1||medication adherence:1||mass screening:1||drug monitoring:1||ARDS:1||Factor XIII:1||histological type:1||severity of illness:1||Proteomic analysis:1||Rhinomanometry:1||definition.:1||Echinococcosis:1||Computed Tomograrhy:1||obstructive sleep apnoea:1||positional therapy:1||Hematopoietic stem cell transplantation:1||Interstitial lung disease:1||ROX index:1||oxygen inhalation therapy:1||Guideline:1||smoking:1||Cholecystitis:1||Surgery:1||Hypoxemia:1||Chronic bronchitis:1||Vascular endothelial growth factor:1||mouse:1||Acute Lung Injury:1||VentilatorInduced Lung Injury:1||Critical care:1||calibration:1||Chemoradiotherapy:1||Small cell lung carcinoma:1||ERCC1:1||Treponema pallidum:1||consensus:1||Creactive protein:1||behavior therapy:1||obstructive:1||sleep apnea:1||outcome:1||Immunocompetence:1||XRay:1||Primary pulmonary Choriocarcinoma:1||positional sleep apnea and snoring:1||plasma circulating cellfree DNA:1||high flow nasal cannula:1||Severity:1||education level:1||Whole Genome Sequencing:1||microbial sensitivity tests:1||Digital tomosynthesis:1||Airway disease:1||Radiation dose:1||upper airway cough syndrome:1||Bacterial:1||Serum:1||Data collection:1||Transglutaminase 2:1||Thymidylate synthase:1||Multiple pulmonary nodules:1||Body weight:1||Critical care personnel:1||Hypertension:1||Fibrosis:1||Celiac artery:1||chronic obstructive:1||Benign metastasizing leiomyoma:1||obstructive sleep apnea:1||multidrugresistant bacteria:1||oxygen therapy:1||hyperphosphatemia:1||hypophosphatemia:1||Asian Continental Ancestry Group:1||severity:1||tuberculosis:1||Computed tomography:1||Lung diseases:1||Lymph nodes:1||Performance status:1||Parameters:1||Bronchogenic cyst:1||Sepsis resuscitation bundle:1||Incidence:1||pneumonia:1||Thymus Neoplasms:1||Bronchopulmonary sequestration:1||Respiratory system abnormalities:1||haptoglobin:1||Hemothorax:1||Lymphomatoid granulomatosis:1||Pneumothorax:1||respiratory distress syndrome:1||critical illness:1||Acinetobacter baumannii:1||antimicrobial peptide:1||hypoxia:1||artificial:1||Tuberculin Test:1||InterferonGamma Release Tests:1||Treatment outcome:1||Receptor:1||Chest radiography:1||ChurgStrauss syndrome:1||multidrug resistance:1||moxifloxacin:1||Hydrogen chloride:1||Inhalation:1||Lung injury:1||adipose stem cell:1||bleomycin:1||Cardiopulmonary resuscitation:1||Rapid response system:1||intensive care unit:1||acute lung injury:1||Mycobacterium avium complex:1||Genes:1||Polymorphism:1||cardiovascular diseases:1||sleep disorders:1||Pleura:1||Herpesvirus 3, human:1||apolipoprotein M:1||prediction model:1||gold nanoparticle:1||highflow nasal cannula:1||phosphate:1||critical care:1||Propensity score matching:1||chronic obstructive pulmonary disease:1||cough:1||Programmed death ligand 1:1||epidermal growth factor:1||chronic cough:1||Chronic obstructive pulmonary disease:1||Intensive care unit:1||nonsmallcell lung carcinoma:1||Limitedstage:1||Syphilis:1||Nontuberculous mycobacteria:1||Intensive care units:1||Sepsis management bundle:1||Single nucleotides:1||miliary tuberculosis:1||H1N1 influenza:1||Chickenpox:1||Multiple Primary:1||Lipopolysaccharides:1||paraoxonase1:1||human:1||Monoclonal antibodies:1||hypoxemia:1||:1||Disease Management:1||socioeconomic status:1||questionnaire:1||KNHANES:1||cycloserine:1||Chest radiograph:1||CT:1||Intensive care:1||Hospital mortality:1||Nterminal proBtype natriuretic peptide:1||neoplasm staging:1||Start of any treatment until the end of radiotherapy:1||Predictive marker:1||Lung adenocarcinoma:1||Nasal obstruction:1||Reference values:1||Sepsis:1||posture:1||serum:1||response surface analysis:1||Adults:1||Correlates:1||Excessive daytime sleepiness:1||matrix metalloproteinase 13:1||TXNL2 protein:1||Lung nodules:1||reintubation:1||hospital mortality:1||respiration:1||Coronavirus disease 2019:1||Critically ill patients:1||Cough:1||Cohort Studies:1||incidence:1||reliability:1||validity:1||Mycobacterium tuberculosis:1||Interstitial:1||nasal:1||Tuberculosis:1||prothionamide:1||Acute respiratory failure:1||Outcome:1||cell therapy:1||pulmonary fibrosis:1||Respiratory Distress Syndrome, Adult:1||Biologic markers:1||Pleural effusion:1||Parapneumonic effusion:1||discrimination:1||Chemotherapy:1||Pulmonary adenocarcinoma:1||Compliance:1||South Korea:1||Taenia:1||Choriocarcinoma:1||Prevalence:1||pulmonary disease:1||Combination chemotherapy:1||Hysterectomy:1||Myomectomy:1||extubation:1||

STATISTICS: Total View :6,964,632; Today View :121

RSS_1.0 RSS_2.0 ATOM_1.0

145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE